Caroline Brennan

Neurosurgery communications, @MDAndersonNews. Opinions my own. Say hi @txbraintrust.bsky.social!

[Jeffrey S. Weinberg @DrJeffWeinberg]

Thrilled to publish the results of the ROADS trial for newly dx’d brain mets requiring surgery. The results define a new standard. Congrats Dr. Beckham and all co-authors! @jco_asco
@UTMDAnderson @ASCO #oncsurgery https://t.co/Yr3mvb9NKS @NSTumorSection

[Caroline Brennan @txbraintrust]

Compelling research from @DrJeffWeinberg at @UTMDAnderson could change standard of care for #brain metastases ⬇️ #oncsurgery #endcancer

https://t.co/82oPMovgtv

[Caroline Brennan @txbraintrust]

Incredible day at the @UTMDAnderson Cancer Neuroscience Program Scientific Retreat today. Great to spend time with researchers and rising stars in the field. As usual, Neurosurgery had a huge turnout. Congratulations to our team! #endcancer #oncsurgery
#cancerneuroscience

[Caroline Brennan @txbraintrust]

On Glioblastoma Awareness Day, we honor our patients, caregivers, providers and researchers. @UTMDAnderson neurosurgeons, clinicians and researchers confront this disease every day.

Learn more about the signs and symptoms: #GBM #oncsurgery #endcancer

https://t.co/13esqQHUdL

[Caroline Brennan @txbraintrust]

More updates on glioma surgery from @UTMDAnderson’s neurosurgery team! #oncsurgery #endcancer

[Christina Abi Faraj @ChristinaAFaraj]

Check it out! 😊
We provide a comprehensive review of Intraop technological advances in glioma surgery! @DrJeffWeinberg @ChrisYoungNSG @txbraintrust @JNeurooncol

https://t.co/sdgH2F2oWF

[Caroline Brennan @txbraintrust]

Check out the latest from Neurosurgery at @UTMDAnderson! #oncsurgery #endcancer

[Christina Abi Faraj @ChristinaAFaraj]

Pituitary carcinoma is rare, aggressive, and notoriously difficult to manage. We report our 30-year surgical experience with 20 patients - one of the largest single-institution series to date.
@MDPIOpenAccess @txbraintrust

https://t.co/SBxOQDbyT3

[Christina Abi Faraj @ChristinaAFaraj]

Check out our comprehensive review of the mechanisms and management of hypopituitarism following SRS for pituitary adenomas! @JNeurooncol @txbraintrust

https://t.co/7rOpi3DqP1

[Jeffrey S. Weinberg @DrJeffWeinberg]

Read how the results of the ROADS trial impacts patient care. @asco #asco2026 @brandon_imber @Dr_N_Moss @KimberlyBHoang @patelnv @AlexandraPaulMD @NSTumorSection @LindseySloan19 #oncsurgery @HTawbi_MDPhD #endcancer

[Caroline Brennan @txbraintrust]

Great to see @UTMDAnderson Neurosurgery leadership @FrederickLangMD discussing hope for glioblastoma with Dr. Jim
Allison at #AANS2026 #oncsurgery #endcancer

[Chiba Ene @ChibaEne_MDPhD]

@FrederickLangMD interview with Dr. Jim Allison on his Nobel prize winning work on CTLA4 checkpoint inhibitors that cure previously fatal cancers like melanoma. Inspirational work that gives us hope for curing the currently fatal GBM @UTMDAnderson @txbraintrust @AANSNeuro

[Caroline Brennan @txbraintrust]

Great presentation at Neurosurgery Grand Rounds by plastic surgeon Dr. Edward Chang on neurosurgical reconstruction. Interdisciplinary collaboration at @UTMDAnderson
powers our education program and brings the best care to our patients. #oncsurgery #endcancer

[Caroline Brennan @txbraintrust]

Congrats to @ChibaEne_MDPhD and the @UTMDAnderson team, who presented their work at #AACR26! The lab focuses on spatial multiomics to improve glioma treatment. #oncsurgery #endcancer

[Chiba Ene @ChibaEne_MDPhD]

First succeesful Lab showing at AACR 2026, an oral presentation on translating spatial multiomics discoveries into better treatments for gliomas and a poster on FLASH radiotherapy for gliomas. Grateful for an amazing team and supportive collaborators @UTMDAnderson @txbraintrust

[Caroline Brennan @txbraintrust]

At @UTMDAnderson, @DrShaanRaza resects the unresectable. Learn more about how he removed a complex chordoma ⬇️ @ChordomaFDN #oncsurgery #endcancer

https://t.co/NL412HEAku

[Caroline Brennan @txbraintrust]

Neurosurgery’s @BettyKimLab found a way to improve immunotherapy response in glioblastoma models. Learn more about the #oncsurgery research to #endcancer at @UTMDAnderson ⬇️

[UT MD Anderson @UTMDAnderson]

New data from UT MD Anderson researchers found that blocking both CD47 and CD24 proteins heightened the immunotherapy response in GBM models.

What's next for this approach: https://t.co/RgVp06QOkj @BettyKimLab #EndCancer

[UT MD Anderson @UTMDAnderson]

Four exceptional scientists have been appointed to the James P. Allison Institute at UT MD Anderson.

They bring expertise in immune therapy resistance, cancer vaccines, bioengineering, tumor evolution and drug development: https://t.co/h3vdWSF0tv #EndCancer @BettyKimLab @hojong_yoon

[Caroline Brennan @txbraintrust]

Neurosurgery Grand Rounds at @MDAndersonNews kicked off this morning with @HTawbi_MD, melanoma and brain metastasis expert. As usual, we had a full house; residents and fellows were engaged in discussion all morning! #oncsurgery #endcancer

[The Broach Foundation for Brain Cancer Research @broachfdn]

The Broach Foundation exists to fund novel research advancing the prevention, treatment, and cure of brain cancer.

Brain cancer is an extraordinarily challenging disease.

Together we can find a cure for brain cancer! Join us!

#NoOneFightsAlone #endcancer #ResearchIsHope

[Caroline Brennan @txbraintrust]

Congrats @ChristinaAFaraj! Check out the latest brain tumor research from Neurosurgery @MDAndersonNews #oncsurgery #endcancer ⬇️

[Christina Abi Faraj @ChristinaAFaraj]

Just published! 💫 In supratentorial high-grade gliomas, ventricle entry during resection did not increase leptomeningeal metastasis risk or worsen survival - tumor ependymal contact is the key driver.
@DrJeffWeinberg @txbraintrust @TheJNS

https://t.co/xrBhgdfJWX

[Caroline Brennan @txbraintrust]

Excited to share the latest research on #gbm from @ChibaEne_MDPhD and @FrederickLangMD. Neurosurgery at @MDAndersonNews is making progress for our patients #oncsurgery #endcancer ⬇️

[UT MD Anderson @UTMDAnderson]

MD Anderson researchers found that adding an immune booster to a cancer-targeting virus increased survival for some patients with glioblastoma and helped identify blood biomarkers in patients most likely to benefit: https://t.co/ddd1rdhyv9 @FrederickLangMD #EndCancer

[Caroline Brennan @txbraintrust]

Excited to welcome Dr. Hideho Okada of @UCSF to @MDAndersonNews yesterday! He presented his work on T-cell -based immunotherapy strategies for malignant gliomas to a large group of Brain Tumor Center researchers and students—Q&A went overtime!#oncsurgery #endcancer

[Caroline Brennan @txbraintrust]

“One of the best things about our job is that we get to see patients every day. They are our inspiration.”

-Dr. Michael Lim @stanfordnsurg at the @MDAndersonNews Leavens Lecture, “Overcoming the immune microenvironment in GBM.”#oncsurgery #endcancer